speb/financial-data huggingface dataset:
XAU.TO balance_sheet (quarterly, 2025-09-30) — Notes Receivable: 648327.00
XAU.TO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 6943537.00
XAU.TO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -209001.00
XAU.TO income_statement (quarterly, 2025-09-30) — Operating Income: 4987803.00
XAU.TO income_statement (quarterly, 2025-09-30) — Operating Revenue: 39769755.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 12677162.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 113346.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 72752432.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 11452711.00
XAU.TO income_statement (quarterly, 2025-09-30) — Other Gand A: 1392477.00
XAU.TO income_statement (quarterly, 2025-09-30) — Other Income Expense: 2251717.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 16219668.00
XAU.TO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -709482.00
XAU.TO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 2009224.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Other Receivables: 144687.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Payables: 2783121.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 2783121.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 567002.00
XAU.TO income_statement (quarterly, 2025-09-30) — Pretax Income: 6505573.00
XAU.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
XAU.TO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment Properties: -2289715.00
XAU.TO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -46602.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Receivables: 1843315.00
XAU.TO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 31044122.00
XAU.TO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 62102.00
XAU.TO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -644665.00
XAU.TO cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -546482.00
XAU.TO income_statement (quarterly, 2025-09-30) — Research And Development: 269677.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 72573209.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 8922403.00
XAU.TO income_statement (quarterly, 2025-09-30) — Salaries And Wages: 2013574.00
XAU.TO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 3406051.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Share Issued: 12677162.00
XAU.TO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 2013574.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 179085841.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 162866173.00
XAU.TO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 36373.95
XAU.TO income_statement (quarterly, 2025-09-30) — Tax Provision: -263757.00
XAU.TO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.15
XAU.TO balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 23501.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Total Assets: 343881180.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 262463113.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Total Debt: 85995412.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 179085841.00
XAU.TO income_statement (quarterly, 2025-09-30) — Total Expenses: 34781952.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 164795339.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 254924292.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 83377272.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 765135.00
XAU.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items: 242493.00
XAU.TO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 242493.00
XAU.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 7538821.00
XAU.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 1994575.00
XAU.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 61996116.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2359309.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 1565155.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -626900.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 14168109.00
XAU.TO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 12540353.00
XAU.TO income_statement (quarterly, 2025-12-31) — Basic EPS: 1.42
XAU.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 9207754.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1103.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 142588949.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 13397949.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 13397949.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 5730756.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -22159127.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 20768231.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 611051.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -52058.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -293635.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -197356.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -655299.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -587297.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 4339860.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 142588949.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 192944449.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -2540862.00
XAU.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 38769910.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 110045369.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 2579920.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 3212316.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 3212316.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 100373518.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 30562.00
XAU.TO income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 30561.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 30562.00
XAU.TO income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 30561.00
XAU.TO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 13257019.00
XAU.TO income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.35
XAU.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 17849821.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Duefrom Related Parties Current: 23126.00
XAU.TO income_statement (quarterly, 2025-12-31) — EBIT: 18914822.00
XAU.TO income_statement (quarterly, 2025-12-31) — EBITDA: 18945384.00
XAU.TO income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 0.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: 0.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -149665.00
XAU.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 13397949.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 5730756.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Finished Goods: 1720007.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 20767128.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 345642.00
XAU.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -675384.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 9415167.00
XAU.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1815178.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 16212827.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1284443.00
XAU.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 23226206.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Hedging Assets Current: 0.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 0.00
XAU.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 1284381.00
XAU.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1284381.00
XAU.TO income_statement (quarterly, 2025-12-31) — Interest Income: 679779.00
XAU.TO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 679779.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Interest Paid Cfo: -1268545.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 1720007.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 283398824.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -22159127.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Investment Properties: 244201700.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 12654903.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Investmentsin Associatesat Cost: 12654903.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 8925768.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 504550.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Leases: 504550.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 90454375.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 90454375.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 8925768.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -654150.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 12654903.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 779893.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 17570.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -2540862.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 77056426.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 164291.00
XAU.TO income_statement (quarterly, 2025-12-31) — Net Income: 17849821.00
XAU.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 17849821.00
XAU.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 17849821.00
XAU.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 17849821.00
XAU.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 17849821.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 17849821.00
XAU.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 17849821.00
XAU.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -604602.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Net Investment Properties Purchase And Sale: -22175594.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 8271618.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 8271618.00
XAU.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -604602.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 657543.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1103.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 176731622.00
XAU.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 19620768.00
XAU.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 18423897.40
XAU.TO balance_sheet (quarterly, 2025-12-31) — Notes Receivable: 648840.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 20768231.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 509933.00
XAU.TO income_statement (quarterly, 2025-12-31) — Operating Income: 21231631.00
XAU.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 61996116.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 12454462.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 131475.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 91995932.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 9415167.00
XAU.TO income_statement (quarterly, 2025-12-31) — Other Gand A: 1227985.00
XAU.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: -2996588.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 16212827.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 3646564.00
XAU.TO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -2321204.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 168882.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Payables: 2585350.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 2585350.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 745716.00
XAU.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 17630441.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment Properties: -22175594.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1103.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 2499127.00
XAU.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 38769909.00
XAU.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 30562.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -654150.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -2540862.00
XAU.TO income_statement (quarterly, 2025-12-31) — Research And Development: 148836.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 91551095.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 26772224.00
XAU.TO income_statement (quarterly, 2025-12-31) — Salaries And Wages: 587193.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Sale Of Business: 17570.00
XAU.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1815178.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 12454462.00
XAU.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 587193.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 192944449.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 176731622.00
XAU.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -101307.60
XAU.TO income_statement (quarterly, 2025-12-31) — Tax Provision: -219380.00
XAU.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
XAU.TO balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 262006.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 383772342.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 283398824.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 93034295.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 192944449.00
XAU.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 40764485.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 190827893.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 273726973.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 90454375.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 226041.00
XAU.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: -675384.00
XAU.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -675384.00
XAU.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 9671851.00
XAU.TO income_statement (annual, 2026-03-31) — +Operating Expense: 10742876.00
XAU.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 3097314.00
XAU.TO income_statement (annual, 2026-03-31) — +Total Revenue: 224338782.00
XAU.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 52221525.00
XAU.TO balance_sheet (annual, 2026-03-31) — Accounts Payable: 2739983.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 2739983.00
XAU.TO balance_sheet (annual, 2026-03-31) — Accounts Receivable: 2539895.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 2539895.00
XAU.TO balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -651043.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -651043.00
XAU.TO balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 14156126.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 14156126.00
XAU.TO cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 221461.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 6841.00
XAU.TO cash_flow (annual, 2026-03-31) — Amortization Of Intangibles: 221461.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 6841.00
XAU.TO cash_flow (annual, 2026-03-31) — Beginning Cash Position: 12731028.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 13397949.00
XAU.TO cash_flow (annual, 2026-03-31) — Capital Expenditure: -56438.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -8733.00
XAU.TO balance_sheet (annual, 2026-03-31) — Capital Stock: 142923804.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 142923804.00
XAU.TO balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 45263578.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 45263578.00
XAU.TO balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 48551772.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 48551772.00
XAU.TO cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Financing Activities: -32694575.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -33964869.00
XAU.TO cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Investing Activities: 16665537.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 53335548.00
XAU.TO cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Operating Activities: 48785053.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 12541816.00
XAU.TO cash_flow (annual, 2026-03-31) — Change In Inventory: 1757441.00
XAU.TO cash_flow (annual, 2026-03-31) — Change In Other Working Capital: -1163608.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -920408.00
XAU.TO cash_flow (annual, 2026-03-31) — Change In Payables And Accrued Expense: -2172396.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 64947.00
XAU.TO cash_flow (annual, 2026-03-31) — Change In Prepaid Assets: -24975.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 573858.00
XAU.TO cash_flow (annual, 2026-03-31) — Change In Receivables: -1658288.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: -858886.00
XAU.TO cash_flow (annual, 2026-03-31) — Change In Working Capital: -3261826.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -2840797.00
XAU.TO cash_flow (annual, 2026-03-31) — Changes In Account Receivables: -1658288.00
XAU.TO cash_flow (annual, 2026-03-31) — Changes In Cash: 32756015.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: 31912495.00
XAU.TO balance_sheet (annual, 2026-03-31) — Common Stock: 142923804.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 142923804.00
XAU.TO balance_sheet (annual, 2026-03-31) — Common Stock Equity: 223135907.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 223135907.00
XAU.TO cash_flow (annual, 2026-03-31) — Common Stock Payments: -7594009.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -1883870.00
XAU.TO income_statement (annual, 2026-03-31) — Cost Of Revenue: 161770249.00
XAU.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 34188043.00
XAU.TO balance_sheet (annual, 2026-03-31) — Current Assets: 154138264.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 154138264.00
XAU.TO balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 2581600.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 2581600.00
XAU.TO balance_sheet (annual, 2026-03-31) — Current Deferred Liabilities: 2291908.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 2291908.00
XAU.TO balance_sheet (annual, 2026-03-31) — Current Deferred Revenue: 2291908.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 2291908.00
XAU.TO balance_sheet (annual, 2026-03-31) — Current Liabilities: 104686352.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 104686352.00
XAU.TO cash_flow (annual, 2026-03-31) — Deferred Income Tax: 2666970.00
XAU.TO cash_flow (annual, 2026-03-31) — Deferred Tax: 2666970.00
XAU.TO cash_flow (annual, 2026-03-31) — Depreciation: 90221.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Depreciation: 24148.00
XAU.TO cash_flow (annual, 2026-03-31) — Depreciation Amortization Depletion: 311682.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 30988.00
XAU.TO income_statement (annual, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 311682.00
XAU.TO income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 30989.00
XAU.TO cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 311682.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 30988.00
XAU.TO income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 311682.00
XAU.TO income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 30989.00
XAU.TO income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 64097670.00
XAU.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 29982758.00
XAU.TO balance_sheet (annual, 2026-03-31) — Duefrom Related Parties Current: 18516.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Duefrom Related Parties Current: 18516.00
XAU.TO income_statement (annual, 2026-03-31) — EBIT: 71886457.00
XAU.TO income_statement (quarterly, 2026-03-31) — EBIT: 33785346.00
XAU.TO income_statement (annual, 2026-03-31) — EBITDA: 72198139.00
XAU.TO income_statement (quarterly, 2026-03-31) — EBITDA: 33816335.00
XAU.TO income_statement (annual, 2026-03-31) — Earnings From Equity Interest: 872257.00
XAU.TO income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 872257.00
XAU.TO cash_flow (annual, 2026-03-31) — Earnings Losses From Equity Investments: -872257.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: -872257.00
XAU.TO cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: -223465.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -46866.00
XAU.TO cash_flow (annual, 2026-03-31) — End Cash Position: 45263578.00
XAU.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 45263578.00
XAU.TO cash_flow (annual, 2026-03-31) — Financing Cash Flow: -32694575.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -33964869.00
XAU.TO balance_sheet (annual, 2026-03-31) — Finished Goods: 4559964.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Finished Goods: 4559964.00
XAU.TO cash_flow (annual, 2026-03-31) — Free Cash Flow: 48728615.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 12533083.00
XAU.TO cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -14909035.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -15679117.00
XAU.TO income_statement (annual, 2026-03-31) — Gain On Sale Of Security: 14552197.00
XAU.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 15817654.00
XAU.TO balance_sheet (annual, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 9300995.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 9300995.00
XAU.TO income_statement (annual, 2026-03-31) — General And Administrative Expense: 9717804.00
XAU.TO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 2917594.00
XAU.TO balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 16205986.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 16205986.00
XAU.TO balance_sheet (annual, 2026-03-31) — Gross PPE: 1293157.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1293157.00
XAU.TO income_statement (annual, 2026-03-31) — Gross Profit: 62568533.00
XAU.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 18033482.00
XAU.TO balance_sheet (annual, 2026-03-31) — Hedging Assets Current: 0.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 0.00
XAU.TO income_statement (annual, 2026-03-31) — Impairment Of Capital Assets: -1759274.00
XAU.TO balance_sheet (annual, 2026-03-31) — Income Tax Payable: 2554308.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 2554308.00
XAU.TO income_statement (annual, 2026-03-31) — Interest Expense: 5121817.00
XAU.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 1238344.00
XAU.TO income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 5121817.00
XAU.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1238344.00
XAU.TO income_statement (annual, 2026-03-31) — Interest Income: 2877072.00
XAU.TO income_statement (quarterly, 2026-03-31) — Interest Income: 1019618.00
XAU.TO income_statement (annual, 2026-03-31) — Interest Income Non Operating: 2877072.00
XAU.TO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 1019618.00
XAU.TO cash_flow (annual, 2026-03-31) — Interest Paid Cfo: -4684994.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Interest Paid Cfo: 0.00
XAU.TO balance_sheet (annual, 2026-03-31) — Inventory: 4559964.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 4559964.00
XAU.TO balance_sheet (annual, 2026-03-31) — Invested Capital: 279922471.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 279922471.00
XAU.TO cash_flow (annual, 2026-03-31) — Investing Cash Flow: 16665537.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 53335548.00
XAU.TO balance_sheet (annual, 2026-03-31) — Investment Properties: 200228204.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Investment Properties: 200228204.00
XAU.TO balance_sheet (annual, 2026-03-31) — Investments And Advances: 13394255.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 13394255.00
XAU.TO balance_sheet (annual, 2026-03-31) — Investmentsin Associatesat Cost: 13394255.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Investmentsin Associatesat Cost: 13394255.00
XAU.TO cash_flow (annual, 2026-03-31) — Issuance Of Debt: 8689634.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: -236134.00
XAU.TO balance_sheet (annual, 2026-03-31) — Land And Improvements: 504550.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 504550.00
XAU.TO balance_sheet (annual, 2026-03-31) — Leases: 504550.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Leases: 504550.00
XAU.TO balance_sheet (annual, 2026-03-31) — Long Term Debt: 56786564.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 56786564.00
XAU.TO balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 56786564.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 56786564.00
XAU.TO cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 8689634.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: -236134.00
XAU.TO cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -35564450.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -33619115.00
XAU.TO balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 13394255.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 13394255.00
XAU.TO balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 788607.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 788607.00
XAU.TO cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: 68407287.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 68394604.00
XAU.TO cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: -7594009.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -1883870.00
XAU.TO balance_sheet (annual, 2026-03-31) — Net Debt: 11522986.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Net Debt: 11522986.00
XAU.TO cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 356838.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 155209.00
XAU.TO income_statement (annual, 2026-03-31) — Net Income: 64097670.00
XAU.TO income_statement (quarterly, 2026-03-31) — Net Income: 29982758.00
XAU.TO income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 64097670.00
XAU.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 29982758.00
XAU.TO income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 64097670.00
XAU.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 29982758.00
XAU.TO income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 64097670.00
XAU.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 29982758.00
XAU.TO income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 64097670.00
XAU.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 29982758.00
XAU.TO cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 64097670.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 29982758.00
XAU.TO income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 64097670.00
XAU.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 29982758.00
XAU.TO income_statement (annual, 2026-03-31) — Net Interest Income: -2244745.00
XAU.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -218726.00
XAU.TO cash_flow (annual, 2026-03-31) — Net Investment Properties Purchase And Sale: -48397118.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Net Investment Properties Purchase And Sale: -11762129.00
XAU.TO cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -3288194.00
XAU.TO cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -26874816.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -33855249.00
XAU.TO cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -26874816.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -33855249.00
XAU.TO income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -2244745.00
XAU.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -218726.00
XAU.TO balance_sheet (annual, 2026-03-31) — Net PPE: 642114.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 642114.00
XAU.TO cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -56438.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -8733.00
XAU.TO balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 206929921.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 206929921.00
XAU.TO income_statement (annual, 2026-03-31) — Normalized EBITDA: 55886668.00
XAU.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 16239407.00
XAU.TO income_statement (annual, 2026-03-31) — Normalized Income: 48437774.50
XAU.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 13790643.64
XAU.TO balance_sheet (annual, 2026-03-31) — Notes Receivable: 649643.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Notes Receivable: 649643.00
XAU.TO cash_flow (annual, 2026-03-31) — Operating Cash Flow: 48785053.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 12541816.00
XAU.TO cash_flow (annual, 2026-03-31) — Operating Gains Losses: -15424454.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -16396165.00
XAU.TO income_statement (annual, 2026-03-31) — Operating Income: 51825657.00
XAU.TO income_statement (quarterly, 2026-03-31) — Operating Income: 14936168.00
XAU.TO income_statement (annual, 2026-03-31) — Operating Revenue: 224338782.00
XAU.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 52221525.00
XAU.TO balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 12539862.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 12539862.00
XAU.TO balance_sheet (annual, 2026-03-31) — Other Current Assets: 88643.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 88643.00
XAU.TO balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 94518553.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 94518553.00
XAU.TO balance_sheet (annual, 2026-03-31) — Other Equity Adjustments: 9300995.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 9300995.00
XAU.TO income_statement (annual, 2026-03-31) — Other Gand A: 6684545.00
XAU.TO income_statement (quarterly, 2026-03-31) — Other Gand A: 2485102.00
XAU.TO income_statement (annual, 2026-03-31) — Other Income Expense: 17183728.00
XAU.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: 17829560.00
XAU.TO balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 16205986.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 16205986.00
XAU.TO cash_flow (annual, 2026-03-31) — Other Non Cash Items: 3559844.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 178668.00
XAU.TO balance_sheet (annual, 2026-03-31) — Other Receivables: 566954.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Other Receivables: 566954.00
XAU.TO balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 3288194.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 3288194.00
XAU.TO balance_sheet (annual, 2026-03-31) — Payables: 5294291.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Payables: 5294291.00
XAU.TO balance_sheet (annual, 2026-03-31) — Payables And Accrued Expenses: 5294291.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 5294291.00
XAU.TO balance_sheet (annual, 2026-03-31) — Prepaid Assets: 3351265.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 3351265.00
XAU.TO income_statement (annual, 2026-03-31) — Pretax Income: 66764640.00
XAU.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 32547002.00
XAU.TO cash_flow (annual, 2026-03-31) — Proceeds From Stock Option Exercised: 1774250.00
XAU.TO cash_flow (annual, 2026-03-31) — Purchase Of Business: -4887.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Business: 0.00
XAU.TO cash_flow (annual, 2026-03-31) — Purchase Of Investment: -3288194.00
XAU.TO cash_flow (annual, 2026-03-31) — Purchase Of Investment Properties: -48397118.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Investment Properties: -11762129.00
XAU.TO cash_flow (annual, 2026-03-31) — Purchase Of PPE: -56438.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -8733.00
XAU.TO balance_sheet (annual, 2026-03-31) — Receivables: 3358816.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 3358816.00
XAU.TO income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 161770249.00
XAU.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 34188044.00
XAU.TO income_statement (annual, 2026-03-31) — Reconciled Depreciation: 311682.00
XAU.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 30988.00
XAU.TO cash_flow (annual, 2026-03-31) — Repayment Of Debt: -35564450.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -33619115.00
XAU.TO cash_flow (annual, 2026-03-31) — Repurchase Of Capital Stock: -7594009.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -1883870.00
XAU.TO income_statement (annual, 2026-03-31) — Research And Development: 713390.00
XAU.TO income_statement (quarterly, 2026-03-31) — Research And Development: 148731.00
XAU.TO balance_sheet (annual, 2026-03-31) — Restricted Cash: 94227804.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 94227804.00
XAU.TO balance_sheet (annual, 2026-03-31) — Retained Earnings: 56754982.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 56754982.00
XAU.TO income_statement (annual, 2026-03-31) — Salaries And Wages: 3033259.00
XAU.TO income_statement (quarterly, 2026-03-31) — Salaries And Wages: 432492.00
XAU.TO cash_flow (annual, 2026-03-31) — Sale Of Business: 68412174.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Sale Of Business: 68394604.00
XAU.TO income_statement (annual, 2026-03-31) — Selling General And Administration: 9717804.00
XAU.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 2917594.00
XAU.TO balance_sheet (annual, 2026-03-31) — Share Issued: 12539862.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 12539862.00
XAU.TO income_statement (annual, 2026-03-31) — Special Income Charges: 1759274.00
XAU.TO cash_flow (annual, 2026-03-31) — Stock Based Compensation: 3033259.00
XAU.TO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 432492.00
XAU.TO balance_sheet (annual, 2026-03-31) — Stockholders Equity: 223135907.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 223135907.00
XAU.TO balance_sheet (annual, 2026-03-31) — Tangible Book Value: 206929921.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 206929921.00
XAU.TO income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 651575.50
XAU.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 1384813.64
XAU.TO income_statement (annual, 2026-03-31) — Tax Provision: 2666970.00
XAU.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 2564244.00
XAU.TO income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.04
XAU.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.08
XAU.TO balance_sheet (annual, 2026-03-31) — Taxes Receivable: 150762.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 150762.00
XAU.TO cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -1513098.00
XAU.TO balance_sheet (annual, 2026-03-31) — Total Assets: 384608823.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 384608823.00
XAU.TO balance_sheet (annual, 2026-03-31) — Total Capitalization: 279922471.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 279922471.00
XAU.TO balance_sheet (annual, 2026-03-31) — Total Debt: 59368164.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 59368164.00
XAU.TO balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 223135907.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 223135907.00
XAU.TO income_statement (annual, 2026-03-31) — Total Expenses: 172513125.00
XAU.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 37285357.00
XAU.TO balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 161472916.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 161472916.00
XAU.TO balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 230470559.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 230470559.00
XAU.TO balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 56786564.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 56786564.00
XAU.TO balance_sheet (annual, 2026-03-31) — Total Tax Payable: 2554308.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 2554308.00
XAU.TO income_statement (annual, 2026-03-31) — Total Unusual Items: 16311471.00
XAU.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: 17576928.00
XAU.TO income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 16311471.00
XAU.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 17576928.00
XAU.TO balance_sheet (annual, 2026-03-31) — Working Capital: 49451912.00
XAU.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: 49451912.00
XBIO balance_sheet (annual, 2021-12-31) — Accumulated Depreciation: -50243.00
XBIO cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 0.00
XBIO cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Financing Activities: 11454545.00
XBIO cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Investing Activities: 0.00
XBIO cash_flow (annual, 2021-12-31) — Common Stock Issuance: 11450866.00
XBIO cash_flow (annual, 2021-12-31) — Deferred Income Tax: 0.00
XBIO cash_flow (annual, 2021-12-31) — Deferred Tax: 0.00
XBIO cash_flow (annual, 2021-12-31) — Depreciation: 35482.00
XBIO cash_flow (annual, 2021-12-31) — Depreciation Amortization Depletion: 35482.00
XBIO cash_flow (annual, 2021-12-31) — Depreciation And Amortization: 35482.00
XBIO cash_flow (annual, 2021-12-31) — Financing Cash Flow: 11454545.00
XBIO balance_sheet (annual, 2021-12-31) — Gross PPE: 50243.00
XBIO income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 0.00
XBIO cash_flow (annual, 2021-12-31) — Investing Cash Flow: 0.00
XBIO cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 11450866.00
XBIO balance_sheet (annual, 2021-12-31) — Machinery Furniture Equipment: 50243.00
XBIO cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: 11450866.00
XBIO cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: 0.00
XBIO balance_sheet (annual, 2021-12-31) — Net PPE: 0.00
XBIO balance_sheet (annual, 2021-12-31) — Prepaid Assets: 479399.00
XBIO cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 3679.00
XBIO cash_flow (annual, 2021-12-31) — Purchase Of Intangibles: 0.00
XBIO income_statement (annual, 2021-12-31) — Reconciled Depreciation: 35482.00
XBIO income_statement (annual, 2021-12-31) — Special Income Charges: 0.00
XBIO income_statement (annual, 2021-12-31) — Tax Provision: 0.00
XBIO income_statement (annual, 2021-12-31) — Total Unusual Items: 0.00
XBIO income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: 0.00
XBIO income_statement (annual, 2022-12-31) — +Operating Expense: 8424833.00
XBIO income_statement (annual, 2022-12-31) — +Total Revenue: 1706925.00
XBIO balance_sheet (annual, 2022-12-31) — Accounts Payable: 287360.00
XBIO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 207769904.00
XBIO income_statement (annual, 2022-12-31) — Basic Average Shares: 1422443.00
XBIO income_statement (annual, 2022-12-31) — Basic EPS: -4.61
XBIO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 18244030.00
XBIO cash_flow (annual, 2022-12-31) — Capital Expenditure: -500000.00
XBIO balance_sheet (annual, 2022-12-31) — Capital Stock: 4294.00
XBIO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 13097265.00
XBIO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 13097265.00
XBIO balance_sheet (annual, 2022-12-31) — Cash Financial: 13097265.00
XBIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 0.00
XBIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -500000.00
XBIO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -4646765.00
XBIO cash_flow (annual, 2022-12-31) — Change In Account Payable: -347947.00
XBIO cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 25000.00
XBIO cash_flow (annual, 2022-12-31) — Change In Payable: -347947.00
XBIO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -347947.00
XBIO cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -103738.00
XBIO cash_flow (annual, 2022-12-31) — Change In Working Capital: -426685.00
XBIO cash_flow (annual, 2022-12-31) — Changes In Cash: -5146765.00
XBIO balance_sheet (annual, 2022-12-31) — Common Stock: 1520.00
XBIO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 13644360.00
XBIO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
XBIO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 745847.00
XBIO balance_sheet (annual, 2022-12-31) — Current Assets: 13653359.00
XBIO balance_sheet (annual, 2022-12-31) — Current Liabilities: 1073156.00
XBIO cash_flow (annual, 2022-12-31) — Depreciation: 27043.00
XBIO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 27043.00
XBIO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 27043.00
XBIO income_statement (annual, 2022-12-31) — Diluted Average Shares: 1422443.00
XBIO income_statement (annual, 2022-12-31) — Diluted EPS: -4.61
XBIO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -6552353.00
XBIO income_statement (annual, 2022-12-31) — EBIT: -6717908.00
XBIO income_statement (annual, 2022-12-31) — EBITDA: -6690865.00
XBIO cash_flow (annual, 2022-12-31) — End Cash Position: 13097265.00
XBIO cash_flow (annual, 2022-12-31) — Financing Cash Flow: 0.00
XBIO cash_flow (annual, 2022-12-31) — Free Cash Flow: -5146765.00
XBIO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 253734.00
XBIO income_statement (annual, 2022-12-31) — General And Administrative Expense: 3653999.00
XBIO income_statement (annual, 2022-12-31) — Interest Income: 167152.00
XBIO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 167152.00
XBIO cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 0.00
XBIO balance_sheet (annual, 2022-12-31) — Invested Capital: 13644360.00
XBIO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -500000.00
XBIO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
XBIO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
XBIO income_statement (annual, 2022-12-31) — Net Income: -6552353.00
XBIO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -6552353.00
XBIO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -6552353.00
XBIO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -6552353.00
XBIO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -6552353.00
XBIO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -6552353.00
XBIO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -6552353.00
XBIO cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -500000.00
XBIO income_statement (annual, 2022-12-31) — Net Interest Income: 167152.00
XBIO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 167152.00
XBIO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 13647134.00